CHRISTINE KRISCH: Open Payments
NPI 1487305967 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 11 payments from 7 companies in 2025. Trend: 2023 $424 · 2024 $619 · 2025 $428
Food & beverage: $358Education: $70
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $193 |
| Actelion Pharmaceuticals US, Inc. | 1 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| United Therapeutics Corporation | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| CVRx, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, OPSUMIT, CAMZYOS, Remodulin, JARDIANCE, Barostim Neo System, WAINUA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
